MustGrow Biologics Corp.

MGRO

CA62822A1030

Biotechnology & Medical Research

Market Closed - Toronto S.E. Other stock markets 03:52:10 2024-04-26 pm EDT			5-day change	1st Jan Change
1 ^CAD	-9.09%		-1.96%	-22.48%

Apr. 23	MustGrow Biologics Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 22	MustGrow Biologics Corp.(TSXV:MGRO) dropped from S&P/TSX Venture Composite Index	CI

MustGrow Biologics Corp.(TSXV:MGRO) dropped from S&P/TSX Venture Composite Index

January 22, 2024 at 12:00 am EST

Latest news about MustGrow Biologics Corp.

MustGrow Biologics Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 23	CI
MustGrow Biologics Corp.(TSXV:MGRO) dropped from S&P/TSX Venture Composite Index	Jan. 22	CI
Mustgrow Biologics Corp. Announces the Signing of Collaboration Agreement with Bayer AG	Dec. 11	CI
MustGrow Biologics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
MustGrow Biologics Corp. Receives Registration Approval for TerraSante in Washington State	Nov. 15	CI
MustGrow Biologics Corp. Receives PMRA Approval to Commence Large Scale Field Trials via NexusBioAg BAT Program	Nov. 07	CI
MustGrow Biologics Corp. Receives USDA Organic Approval for Biological Fertilizer and Soil Amendment Technology	23-10-31	CI
MustGrow Biologics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-28	CI
MustGrow Biologics Corp.(TSXV:MGRO) added to S&P/TSX Venture Composite Index	23-07-24	CI
MustGrow Biologics Corp. Completes Initial Commercial Production Run Via Contract Manufacturer	23-06-13	CI
Mustgrow Biologics Corp. Announce the Signing of Contract Services Agreement with Bio Ag Product Strategies	23-06-05	CI
MustGrow Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-26	CI
MustGrow Biologics Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
MustGrow Biologics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-29	CI

Chart MustGrow Biologics Corp.

Duration

Period

More charts

MustGrow Biologics Corp. is a Canada-based agricultural biotechnology company focused on providing science-based biological solutions for high-value crops. The Company is engaged in developing organic biocontrol, soil amendment and bio fertility products by harnessing the natural defense mechanism and organic materials of the mustard plant to sustainably protect the global food supply. It focuses on the development and commercialization of natural biological technologies and products from mustard seed for sustainable agricultural markets. The Company is providing a natural, organic technology platform with the efficacy of synthetic chemicals that has potential application in multiple global markets. Its technology pipeline includes soil amendment & bio fertility, biocontrol, and postharvest biocontrol & food preservation. The Company is pursuing the adoption and use of its technology in the soil amendment and bio fertility markets.

Sector

Biotechnology & Medical Research

Calendar

2024-05-01 - Planet MicroCap Showcase

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

Average target price

Consensus

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MUSTGROW BIOLOGICS CORP.	-22.48%	37.72M
IQVIA HOLDINGS INC.	+1.51%	42.75B
MODERNA, INC.	+8.57%	41.34B
LONZA GROUP AG	+49.22%	41.61B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research